New Perspectives on Alzheimer's Disease and Nutrition

Journal of Alzheimer's Disease

Volumn 46, Issue 4, 2015, Pages 1111-1127

  Gustafson, Deborah R ^a,b   Clare Morris, Martha ^c   Scarmeas, Nikolaos ^d,e   Shah, Raj C ^f   Sijben, John ^g   Yaffe, Kristine ^h   Zhu, Xiongwei ⁱ  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^e UNIVERSITY OF ATHENS   (Greece)

^f RUSH UNIVERSITY MEDICAL CENTER   (United States)

^g Nutricia Nederland   (Netherlands)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; cognition disorders; diet therapy; neuronal membrane; nutrition

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CHOLINE; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FATTY ACID; FOLIC ACID; POLYUNSATURATED FATTY ACID; RETINOL; SELENIUM; TOCOPHEROL; URIDINE; VITAMIN D;

ALZHEIMER DISEASE; BODY MASS; BRAIN FUNCTION; CONFERENCE PAPER; FAT INTAKE; FATTY ACID BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; HUMAN; LIPID BRAIN LEVEL; MEDITERRANEAN DIET; NERVE CELL MEMBRANE; NONHUMAN; NUTRITION; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; SELENIUM BLOOD LEVEL; VITAMIN BLOOD LEVEL; WEIGHT REDUCTION; DISEASE COURSE; FEMALE; MALE; PSYCHOLOGY;

ALZHEIMER DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; NUTRITIONAL STATUS;

EID: 84937037548     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150084     Document Type: Conference Paper

References (145)

1. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer's disease. Lancet 377, 1019-1031.
2. Cardoso BR, Cominetti C, Cozzolino SM (2013) Importance and management of micronutrient deficiencies in patients with Alzheimer's disease. Clin Interv Aging 8, 531-542.
3. Mi W, van Wijk N, Cansev M, Sijben JW, Kamphuis PJ (2013) Nutritional approaches in the risk reduction and management of Alzheimer's disease. Nutrition 29, 1080-1089.
4. Kamphuis PJ, Scheltens P (2010) Can nutrients prevent or delay onset of Alzheimer's disease? J Alzheimers Dis 20, 765-775.
5. Barnard ND, Bush AI, Ceccarelli A, Cooper J, de Jager CA, Erickson KI, Fraser G, Kesler S, Levin SM, Lucey B, Morris MC, Squitti R (2014) Dietary and lifestyle guidelines for the prevention of Alzheimer's disease. Neurobiol Aging 35(Suppl 2), S74-S78.
6. Cooper JK (2014) Nutrition and the brain: What advice should we give? Neurobiol Aging 35 (Suppl 2), S79-S83.
7. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP Jr, Yaffe K (2005) Obesity in middle age and future risk of dementia: A 27 year longitudinal population based study. BMJ 330, 1360.
8. Gustafson DR, Ba¨ckman K, Joas E, Waern M, O¨stling S, Guo X, Skoog I (2012) 37 years of body mass index and dementia: Observations from the prospective population study of women in Gothenburg, Sweden. J Alzheimers Dis 28, 163-171.
9. Gustafson DR, Luchsinger JA (2013) High adiposity: Risk factor for dementia and Alzheimer's disease? Alzheimers Res Ther 5, 57.
10. Emmerzaal TL, Kiliaan AJ, Gustafson DR (2015) 2003-2013: A decade of body mass index, Alzheimer's disease, and dementia. J Alzheimers Dis 43, 739-755.
11. Qizilbash N, Gregson J, Johnson ME, Pearce N, Douglas I, Wing K, Evans SJ, Pocock SJ (2015) BMI and risk of dementia in two million people over two decades: A retrospective cohort study. Lancet Diabetes Endocrinol, doi: 10.1016/S2213-8587(15)00033-9.
12. Kiliaan AJ, Arnoldussen IA, Gustafson DR (2014) Adipokines: A link between obesity and dementia? Lancet Neurol 13, 913-923.
13. Besser LM, Gill DP, Monsell SE, Brenowitz W, Meranus DH, Kukull W, Gustafson DR (2014) Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord 28, 36-43.
14. Gu Y, Scarmeas N, Cosentino S, Brandt J, Albert M, Blacker D, Dubois B, Stern Y (2014) Change in body mass index before and after Alzheimer's disease onset. Curr Alzheimer Res 11, 349-356.
15. Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA (2005) Change in body mass index and risk of incident Alzheimer disease. Neurology 65, 892-897.
16. Soto ME, Secher M, Gillette-Guyonnet S, Abellan van Kan G, Andrieu S, Nourhashemi F, Rolland Y, Vellas B (2012) Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease. J Alzheimers Dis 28, 647-654.
17. Cronk BB, Johnson DK, Burns JM, Alzheimer's Disease Neuroimaging, Initiative (2010) Body mass index and cognitive decline in mild cognitive impairment. Alzheimer Dis Assoc Disord 24, 126-130.
18. Mahley RW, Weisgraber KH, Huang Y (2006) Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci USA103, 5644-5651.
19. Sing CF, Davignon J (1985) Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37, 268-285.
20. Gustafson DR (2010) Adiposity hormones and dementia. J Neurol Sci 299, 30-34.
21. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115, 911-919.
22. Zeki Al Hazzouri A, Stone KL, Haan MN, Yaffe K (2013) Leptin, mild cognitive impairment, and dementia among elderly women. J Gerontol A Biol Sci Med Sci 68, 175-180.
23. World Health Organization. Heath topics: Nutrition disorders. http://www.who.int/topics/nutrition disorders/en/. Accessed September 2014.
24. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
25. Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ (2013) Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurol 12, 207-216.
26. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791.
27. Wurtman RJ, Cansev M, Sakamoto T, Ulus IH (2009) Use of phosphatide precursors to promote synaptogenesis. Annu Rev Nutr 29, 59-87.
28. Bradford Hill A (1965) The environment and disease: Association or causation? Proc R Soc Med 58, 295-300.
29. FDA Guidance. Draft Guidance for Industry: Frequently Asked Questions About Medical Foods; Second Edition. http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/MedicalFoods/ucm054048.htm. May 1997; May 2007; Revised August 2013; Accessed September 2014.
30. Proitsi P, Lupton MK, Velayudhan L, Newhouse S, Fogh I, Tsolaki M, Daniilidou M, Pritchard M, Kloszewska I, Soininen H, Mecocci P, Vellas B, Alzheimer's Disease Neuroimaging Initiative, Williams J, GERAD1 Consortium, Stewart R, Sham P, Lovestone S, Powell JF (2014) Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: A Mendelian randomization analysis. PLoS Med 11, e1001713.
31. Morris MC, Schneider JA, Li H, Tangney CC, Nag S, Bennett DA, Honer WG, Barnes LL (2015) Brain tocopherols related to Alzheimer's disease neuropathology in humans. Alzheimers Dement 11, 32-39.
32. Jacques PF, Tucker KL (2001) Are dietary patterns useful for understanding the role of diet in chronic disease? Am J Clin Nutr 73, 1-2.
33. Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA (2006) Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 59, 912-921.
34. Scarmeas N, Stern Y, Mayeux R, Manly JJ, Schupf N, Luchsinger JA (2009) Mediterranean diet and mild cognitive impairment. Arch Neurol 66, 216-225.
35. Scarmeas N, Luchsinger JA, Mayeux R, Stern Y (2007) Mediterranean diet and Alzheimer disease mortality. Neurology 69, 1084-1093.
36. Gu Y, Nieves JW, Stern Y, Luchsinger JA, Scarmeas N (2010) Food combination and Alzheimer disease risk: A protective diet. Arch Neurol 67, 699-706.
37. Vandongen R, Mori TA, Burke V, Beilin LJ, Morris J, Ritchie J (1993) Effects on blood pressure of omega 3 fats in subjects at increased risk of cardiovascular disease. Hypertension 22, 371-379.
38. Mori TA, Vandongen R, Beilin LJ, Burke V, Morris J, Ritchie J (1994) Effects of varying dietary fat, fish, and fish oils on blood lipids in a randomized controlled trial in men at risk of heart disease. Am J Clin Nutr 59, 1060-1068.
39. Mori TA, Beilin LJ, Burke V, Morris J, Ritchie J (1997) Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler Thromb Vasc Biol 17, 279-286.
40. Morris MC, Evans DA, Tangney CC, Bienias JL, Schneider JA, Wilson RS, Scherr PA (2006) Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Arch Neurol 63, 1085-1088.
41. Psaltopoulou T, Sergentanis TN, Panagiotakos DB, Sergentanis IN, Kosti R, Scarmeas N (2013) Mediterranean diet, stroke, cognitive impairment, and depression: A meta-analysis. Ann Neurol 74, 580-591.
42. Scarmeas N, Luchsinger JA, Schupf N, Brickman AM, Cosentino S, Tang MX, Stern Y (2009) Physical activity, diet, and risk of Alzheimer disease. JAMA 302, 627-637.
43. Gardener H, Scarmeas N, Gu Y, Boden-Albala B, Elkind MS, Sacco RL, DeCarli C, Wright CB (2012) Mediterranean diet and white matter hyperintensity volume in the Northern Manhattan Study. Arch Neurol 69, 251-256.
44. Scarmeas N, Luchsinger JA, Stern Y, Gu Y, He J, DeCarli C, Brown T, Brickman AM (2011) Mediterranean diet and magnetic resonance imaging-assessed cerebrovascular disease. Ann Neurol 69, 257-268.
45. Viña J, Lloret A, Giraldo E, Badia MC, Alonso MD (2011) Antioxidant pathways in Alzheimer's disease: Possibilities of intervention. Curr Pharm Des 17, 3861-3864.
46. Clark TA, Lee HP, Rolston RK, Zhu X, Marlatt MW, Castellani RJ, Nunomura A, Casadesus G, Smith MA, Lee HG, Perry G (2010) Oxidative stress and its implications for future treatments and management of Alzheimer disease. Int J Biomed Sci 6, 225-227.
47. Nunomura A, Perry G, Pappolla MA, Friedland RP, Hirai K, Chiba S, Smith MA (2000) Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J Neuropathol Exp Neurol 59, 1011-1017.
48. Tamagno E, Bardini P, Obbili A, Vitali A, Borghi R, Zaccheo D, Pronzato MA, Danni O, Smith MA, Perry G, Tabaton M (2002) Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol Dis 10, 279-288.
49. Reddy PH, Beal MF (2008) Amyloid beta, mitochondrial dysfunction and synaptic damage: Implications for cognitive decline in aging and Alzheimer's disease. Trends Mol Med 14, 45-53.
50. Zhu X, Lee HG, Casadesus G, Avila J, Drew K, Perry G, Smith MA (2005) Oxidative imbalance in Alzheimer's disease. Mol Neurobiol 31, 205-217.
51. Sutherland GT, Chami B, Youssef P, Witting PK (2013) Oxidative stress in Alzheimer's disease: Primary villain or physiological by-product? Redox Rep 18, 134-141.
52. Ansari MA, Scheff SW (2010) Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol 69, 155-167.
53. Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O, Rostaing P, Triller A, Salem N Jr, Ashe KH, Frautschy SA, Cole GM (2004) Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43, 633-645.
54. Otaegui-Arrazola A, Amiano P, Elbusto A, Urdaneta E, Martínez-Lage P (2014) Diet, cognition, and Alzheimer's disease: Food for thought. Eur J Nutr 53, 1-23.
55. Crichton GE, Bryan J, Murphy KJ (2013) Dietary antioxidants, cognitive function and dementia-a systematic review. Plant Foods Hum Nutr 68, 279-292.
56. Farina N, Isaac MG, Clark AR, Rusted J, Tabet N (2012) Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database Syst Rev 11, CD002854.
57. Naughton BJ, Duncan FJ, Murrey DA, Meadows AS, Newsom DE, Stoicea N, White P, Scharre DW, Mccarty DM, Fu H (2015) Blood genome-wide transcriptional profiles reflect broad molecular impairments and strong bloodbrain links in Alzheimer's disease. J Alzheimers Dis 43, 93-108.
58. Yu JT, Tan L (2012) The role of clusterin in Alzheimer's disease: Pathways, pathogenesis, and therapy. Mol Neurobiol 45, 314-326.
59. van Meer G, Voelker DR, Feigenson GW (2008) Membrane lipids: Where they are and how they behave. Nat Rev Mol Cell Biol 9, 112-124.
60. Yehuda S, Rabinovitz S, Carasso RL, Mostofsky DI (2002) The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol Aging 23, 843-853.
61. van Wijk N, Broersen LM, de Wilde MC, Hageman RJ, Groenendijk M, Sijben JW, Kamphuis PJ (2014) Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination. J Alzheimers Dis 38, 459-479.
62. Sidhu VK, Huang BX, Kim HY (2011) Effects of docosahexaenoic acid on mouse brain synaptic plasma membrane proteome analyzed by mass spectrometry and (16)O/(18)O labeling. J Proteome Res 10, 5472-5480.
63. Cao D, Kevala K, Kim J, Moon HS, Jun SB, Lovinger D, Kim HY (2009) Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. J Neurochem 111, 510-521.
64. Bourre JM (2006) Effects of nutrients (in food) on the structure and function of the nervous system: Update on dietary requirements for brain. Part 1: Micronutrients. J Nutr Health Aging 10, 377-385.
65. Bourre JM (2006) Effects of nutrients (in food) on the structure and function of the nervous system: Update on dietary requirements for brain. Part 2 : Macronutrients. J Nutr Health Aging 10, 386-399.
66. Morris MC, Tangney CC (2010) Diet and prevention of Alzheimer disease. JAMA 303, 2519-2520.
67. Panza F, Solfrizzi V, Colacicco AM, D'Introno A, Capurso C, Torres F, Del Parigi A, Capurso S, Capurso A (2004) Mediterranean diet and cognitive decline. Public Health Nutr 7, 959-963.
68. Tangney CC, Li H, Wang Y, Barnes L, Schneider JA, Bennett DA, Morris MC (2014) Relation of DASH- and Mediterranean-like dietary patterns to cognitive decline in older persons. Neurology 83, 1410-1416.
69. Smith PJ, Blumenthal JA, Babyak MA, Craighead L, Welsh-Bohmer KA, Browndyke JN, Strauman TA, Sherwood A (2010) Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure. Hypertension 55, 1331-1338.
70. Morris MC (2009) The role of nutrition in Alzheimer's disease: Epidemiological evidence. Eur J Neurol 16(Suppl 1), 1-7.
71. Willett WC (1998) Nutritional Epidemiology, 2nd Edition, Oxford University Press, New York, pp.
72. Mertz W (1981) The essential trace elements. Science 213, 1332-1338.
73. Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS, Aggarwal NT, Scherr PA (2005) Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr 81, 508-514.
74. Usoro OB, Mousa SA (2010) Vitamin E forms in Alzheimer's disease: A review of controversial and clinical experiences. Crit Rev Food Sci Nutr 50, 414-419.
75. Evans DA, Morris MC, Rajan KB (2014) Vitamin E, memantine, and Alzheimer disease. JAMA 311, 29-30.
76. Jiang Q, Christen S, Shigenaga MK, Ames BN (2001) Gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr 74, 714-722.
77. Liu M, Wallmon A, Olsson-Mortlock C, Wallin R, Saldeen T (2003) Mixed tocopherols inhibit platelet aggregation in humans: Potential mechanisms. Am J Clin Nutr 77, 700-706.
78. Clément M, Bourre JM (1997) Graded dietary levels of RRR-gamma-tocopherol induce a marked increase in the concentrations of alpha- and gamma-tocopherol in nervous tissues, heart, liver and muscle of vitamin-E-deficient rats. Biochim Biophys Acta 1334, 173-181.
79. Morris MC, Tangney CC (2014) Dietary fat composition and dementia risk. Neurobiol Aging 35(Suppl 2), S59-S64.
80. McNamara RK, Liu Y, Jandacek R, Rider T, Tso P (2008) The aging human orbitofrontal cortex: Decreasing polyunsaturated fatty acid composition and associated increases in lipogenic gene expression and stearoyl-CoA desaturase activity. Prostaglandins Leukot Essent Fatty Acids 78, 293-304.
81. Snigdha S, Astarita G, Piomelli D, Cotman CW (2012) Effects of diet and behavioural enrichment on free fatty acids in the aged canine brain. Neuroscience 202, 326-333.
82. Lebbadi M, Julien C, Phivilay A, Tremblay C, Emond V, Kang JX, Calon F (2011) Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease. J Alzheimers Dis 27, 853-869.
83. Hashimoto M, Hossain S (2011) Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: Beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease. J Pharmacol Sci 116, 150-162.
84. Chung WL, Chen JJ, Su HM (2008) Fish oil supplementation of control and (n-3) fatty acid-deficient male rats enhances reference and working memory performance and increases brain regional docosahexaenoic acid levels. J Nutr 138, 1165-1171.
85. Holguin S, Huang Y, Liu J, Wurtman R (2008) Chronic administration of DHA and UMP improves the impaired memory of environmentally impoverished rats. Behav Brain Res 191, 11-16.
86. Sakamoto T, Cansev M, Wurtman RJ (2007) Oral supplementation with docosahexaenoic acid and uridine-5′-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res 1182, 50-59.
87. Lim SY, Suzuki H (2002) Dose-response effect of egg-phosphatidylcholine on maze-learning ability and fatty acid composition of plasma and brain in aged mice fed an n-3 fatty acid-deficient diet. Ann Nutr Metab 46, 215-221.
88. Minami M, Kimura S, Endo T, Hamaue N, Hirafuji M, Togashi H, Matsumoto M, Yoshioka M, Saito H, Watanabe S, Kobayashi T, Okuyama H (1997) Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats. Pharmacol Biochem Behav 58, 1123-1129.
89. Greenwood CE, Winocur G (1996) Cognitive impairment in rats fed high-fat diets: A specific effect of saturated fatty-acid intake. Behav Neurosci 110, 451-459.
90. Puglielli L, Tanzi RE, Kovacs DM (2003) Alzheimer's disease: The cholesterol connection. Nat Neurosci 6, 345-351.
91. Winocur G, Greenwood CE (2005) Studies of the effects of high fat diets on cognitive function in a rat model. Neurobiol Aging 26(Suppl 1), 46-49.
92. Grimm MO, Rothhaar TL, Grösgen S, Burg VK, Hundsdörfer B, Haupenthal VJ, Friess P, Kins S, Grimm HS, Hartmann T (2012) Trans fatty acids enhance amyloidogenic processing of the Alzheimer amyloid precursor protein (APP). J Nutr Biochem 23, 1214-1223.
93. Oksman M, Iivonen H, Hogyes E, Amtul Z, Penke B, Leenders I, Broersen L, Lütjohann D, Hartmann T, Tanila H (2006) Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol Dis 23, 563-572.
94. Sparks DL, Kuo YM, Roher A, Martin T, Lukas RJ (2000) Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations. Ann NY Acad Sci 903, 335-344.
95. Sparks DL, Scheff SW, Hunsaker JC 3rd, Liu H, Landers T, Gross DR (1994) Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 126, 88-94.
96. Takechi R, Pallebage-Gamarallage MM, Lam V, Giles C, Mamo JC (2013) Aging-related changes in blood-brain barrier integrity and the effect of dietary fat. Neurodegener Dis 12, 125-135.
97. Morris MC, Tangney CC, Wang Y, Barnes LL, Bennett D, Aggarwal N (2014) Mind diet score more predictive than dash or Mediterranean diet scores. Alzheimers Dement 10 (4 Suppl), P166 (Abstract O2-02-04).
98. Catalá I, Ferrer I, Galofré E,Fábregues I (1988) Decreased numbers of dendritic spines on cortical pyramidal neurons in dementia. A quantitative Golgi study on biopsy samples. Hum Neurobiol 6, 255-259.
99. Einstein G, Buranosky R, Crain BJ (1994) Dendritic pathology of granule cells in Alzheimer's disease is unrelated to neuritic plaques. J Neurosci 14, 5077-5088.
100. Mavroudis IA, Fotiou DF, Adipepe LF, Manani MG, Njau SD, Psaroulis D, Costa VG, Baloyannis SJ (2010) Morphological changes of the human purkinje cells and deposition of neuritic plaques and neurofibrillary tangles on the cerebellar cortex of Alzheimer's disease. Am J Alzheimers Dis Other Demen 25, 585-591.
101. Tsamis IK, Mytilinaios GD, Njau NS, Fotiou FD, Glaftsi S, Costa V, Baloyannis JS (2010) Properties of CA3 dendritic excrescences in Alzheimer's disease. Curr Alzheimer Res 7, 84-90.
102. Masliah E, Mallory M, Hansen L, DeTeresa R, Alford M, Terry R (1994) Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci Lett 174, 67-72.
103. Scheff SW, Price DA, Schmitt FA, Mufson EJ (2006) Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 27, 1372-1384.
104. Bell KF, Bennett DA, Cuello AC (2007) Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment. J Neurosci 27, 10810-10817.
105. Akram A, Christoffel D, Rocher AB, Bouras C, Kövari E, Perl DP, Morrison JH, Herrmann FR, Haroutunian V, Giannakopoulos P, Hof PR (2008) Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: Relationship with the progression of Alzheimer's disease. Neurobiol Aging 29, 1296-1307.
106. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann Neurol 27, 457-464.
107. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 30, 572-580.
108. Kosicek M, Hecimovic S (2013) Phospholipids and Alzheimer's disease: Alterations, mechanisms and potential biomarkers. Int J Mol Sci 14, 1310-1322.
109. Mielke MM, Lyketsos CG (2006) Lipids and the pathogenesis of Alzheimer's disease: Is there a link? Int Rev Psychiatry 18, 173-186.
110. Gibellini F, Smith TK (2010) The Kennedy pathway-De novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB Life 62, 414-428.
111. Wurtman RJ, Ulus IH, Cansev M, Watkins CJ, Wang L, Marzloff G (2006) Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res 1088, 83-92.
112. Cansev M, van Wijk N, Turkyilmaz M, Orhan F, Sijben JW, Broersen LM (2015) A specific multi-nutrient enriched diet enhances hippocampal cholinergic transmission in aged rats. Neurobiol Aging 36, 344-351.
113. Ai¨d S, Vancassel S, Poumès-Ballihaut C, Chalon S, Guesnet P, Lavialle M (2003) Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus. J Lipid Res 44, 1545-1551.
114. Lopes da Silva S, Vellas B, Elemans S, Luchsinger J, Kamphuis P, Yaffe K, Sijben J, Groenendijk M, Stijnen T (2014) Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta-analysis. Alzheimers Dement 10, 485-502.
115. Lin PY, Chiu CC, Huang SY, Su KP (2012) A meta-analytic review of polyunsaturated fatty acid compositions in dementia. J Clin Psychiatry 73, 1245-1254.
116. Loef M, Schrauzer GN, Walach H (2011) Selenium and Alzheimer's disease: A systematic review. J Alzheimers Dis 26, 81-104.
117. de Wilde MC, van Wijk N, Groenendijk M, Hageman R, Kamphuis PJ, Sijben JW. (2012) Lower plasma uridine concentration in people with Alzheimer's disease than in healthy individuals. Program No. 749.01. 2012 Neuroscience Meeting Planner. Society for Neuroscience, New Orleans, LA.
118. Trushina E, Dutta T, Persson XM, Mielke MM, Petersen RC (2013) Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics. PLoS One 8, e63644.
119. Olde Rikkert MG, Verhey FR, Sijben JW, Bouwman FH, Dautzenberg PL, Lansink M, Sipers WM, van Asselt DZ, van Hees AM, Stevens M, Vellas B, Scheltens P (2014) Differences in nutritional status between very mild Alzheimer's disease patients and healthy controls. J Alzheimers Dis 41, 261-271.
120. Wang G, Zhou Y, Huang FJ, Tang HD, Xu XH, Liu JJ, Wang Y, Deng YL, Ren RJ, Xu W, Ma JF, Zhang YN, Zhao AH, Chen SD, Jia W (2014) Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment. J Proteome Res 13, 2649-2658.
121. Wurtman RJ (2014) A nutrient combination that can affect synapse formation. Nutrients 6, 1701-1710.
122. Czech C, Berndt P, Busch K, Schmitz O, Wiemer J, Most V, Hampel H, Kastler J, Senn H (2012) Metabolite profiling of Alzheimer's disease cerebrospinal fluid. PLoS One 7, e31501.
123. de Wilde MC, Vellas B, Lopes da Silva S, Elemans S, Swinkels S, Sijben JW, Luchsinger JA, Groenendijk M, Yaffe K, Stijnen T (2014) Lower long-chain n-3 fatty acid status in AD: Results from a meta-analysis. Alzheimers Dement 10(Suppl), P674-P675.
124. Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, Wurtman RJ (1992) Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci U S A 89, 1671-1675.
125. Igarashi M, Ma K, Gao F, Kim HW, Rapoport SI, Rao JS (2011) Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex. J Alzheimers Dis 24, 507-517.
126. Grimm MO, Grösgen S, Riemenschneider M, Tanila H, Grimm HS, Hartmann T (2011) From brain to food: Analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry. J Chromatogr A 1218, 7713-7722.
127. Walter A, Korth U, Hilgert M, Hartmann J, Weichel O, Hilgert M, Fassbender K, Schmitt A, Klein J (2004) Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients. Neurobiol Aging 25, 1299-1303.
128. Cohen BM, Renshaw PF, Stoll AL, Wurtman RJ, Yurgelun-Todd D, Babb SM (1995) Decreased brain choline uptake in older adults. An in vivo proton magnetic resonance spectroscopy study. JAMA 274, 902-907.
129. Shatenstein B, Kergoat MJ, Reid I (2007) Poor nutrient intakes during 1-year follow-up with community-dwelling older adults with early-stage Alzheimer dementia compared to cognitively intact matched controls. J Am Diet Assoc 107, 2091-2099.
130. Phillips MA, Childs CE, Calder PC, Rogers PJ (2012) Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: A comparison of individuals with and without cognitive impairment and Alzheimer's disease. Nutr Neurosci 6, 271-277.
131. Hart K, Cave E, Conroy B, Farina N, Young J, Rusted J, Tabet N (2013) Nutritional status of older adults with and without dementia. Proc Nutr Soc 72 (OCE4) E247.
132. Astarita G, Jung KM, Berchtold NC, Nguyen VQ, Gillen DL, Head E, Cotman CW, Piomelli D (2010) Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease. PLoS One 5, e12538.
133. Van Dam F, Van Gool WA (2009) Hyperhomocysteinemia and Alzheimer's disease: A systematic review. Arch Gerontol Geriatr 48, 425-430.
134. Andres E, Affenberger S, Vinzio S, Kurtz JE, Noel E, Kaltenbach G, Maloisel F, Schlienger JL, Blicklé JF (2005) Food-cobalamin malabsorption in elderly patients: Clinical manifestations and treatment. AmJMed118, 1154-1159.
135. Nilsson-Ehle H (1998) Age-related changes in cobalamin (vitamin B12) handling. Implications for therapy. Drugs Aging 12, 277-292.
136. Carmel R (1997) Cobalamin, the stomach, and aging. Am J Clin Nutr 66, 750-759.
137. Refsum H, Smith AD (2003) Low vitamin B-12 status in confirmed Alzheimer's disease as revealed by serum holotranscobalamin. J Neurol Neurosurg Psychiatry 74, 959-961.
138. McCaddon A, Hudson P, Abrahamsson L, Olofsson H, Regland B (2001) Analogues, ageing and aberrant assimilation of vitamin B12 in Alzheimer's disease. Dement Geriatr Cogn Disord 12, 133-137.
139. de Waal H, Stam CJ, Lansbergen MM, Wieggers RL, Kamphuis PJ, Scheltens P, Maestú F, van Straaten EC (2014) The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: A randomised controlled study. PLoS One 9, e86558.
140. Scheltens P, Twisk JW, Blesa R, Scarpini E, von Arnim CA, Bongers A, Harrison J, Swinkels SH, Stam CJ, de Waal H, Wurtman RJ, Wieggers RL, Vellas B, Kamphuis PJ (2012) Efficacy of Souvenaid in mild Alzheimer's disease: Results from a randomized controlled trial. J Alzheimers Dis 31, 225-236.
141. Scheltens P, Kamphuis PJ, Verhey FR, Olde Rikkert MG, Wurtman RJ, Wilkinson D, Twisk JW, Kurz A (2010) Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial. Alzheimers Dement 6, 1-10.e1.
142. Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, MacArthur LH, Hall WJ, Fisher SG, Peterson DR, Haley JM, Nazar MD, Rich SA, Berlau DJ, Peltz CB, Tan MT, Kawas CH, Federoff HJ (2014) Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med 20, 415-418.
143. Hartmann T, van Wijk N, Wurtman RJ, Olde Rikkert MG, Sijben JW, Soininen H, Vellas B, Scheltens P (2014) A nutritional approach to ameliorate altered phospholipid metabolism in Alzheimer's disease. J Alzheimers Dis 41, 715-717.
144. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746.
145. Netherlands Trial Registry. LipiDiDiet Trial. http://www.trialregister.nl/trialreg/admin/rctview.asp? TC=1705. December 23, 2013; Accessed September 2014.